TIGIT blockade in vitro resulted in significantly enhanced killing of neuroblastoma tumoroids by immune cells, when combined with PD-L1 blockade (Figures 7A, 7B, and S8D–S8F). This evidence concerns the gene CD274 and neuroblastoma.